申请人:Sun Lijun
公开号:US20110059893A1
公开(公告)日:2011-03-10
The invention relates to compounds of structural formula (I):
or a pharmaceutically acceptable salt, solvate, clathrate, and prodrug thereof, wherein R
a
, R
b
, and R
2
are defined herein. These compounds inhibit tubulin polymerization and/or target vasculature and are useful for treating proliferative disorders, such as cancer.
本发明涉及结构式(I)的化合物:或其药学上可接受的盐,溶剂合物,笼合物和前药,其中Ra,Rb和R2在此定义。这些化合物抑制微管聚合和/或靶向血管,可用于治疗增殖性疾病,如癌症。